Switch Language
Alt tag

Never miss out on the latest news!

Sign up to the Thrombosis Adviser newsletter.

 

Subscribe

See Also

Peripheral Artery Disease: causes and consequences

Coronary Artery Disease: causes and consequences

Thrombosis Digest 2020

When is the right time to start thinking about renal function in patients with AF?

When is the right time to start thinking about renal function in patients with AF?

When is the right time to start thinking about renal function in patients with AF?

Thrombosis Adviser at the European Society of Cardiology Congress 2020

Thrombosis Adviser at the European Society of Cardiology Congress 2020

Thrombosis Adviser at the European Society of Cardiology Congress 2020

Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it

Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it

Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it

Patients with diabetes and atrial fibrillation: How can the risk of cardiovascular death be reduced?

Patients with diabetes and atrial fibrillation: How can the risk of cardiovascular death be reduced?

Patients with diabetes and atrial fibrillation: How can the risk of cardiovascular death be reduced?

Managing anticoagulation during the COVID-19 pandemic

Managing anticoagulation during the COVID-19 pandemic

Managing anticoagulation during the COVID-19 pandemic

Supporting the treatment of patients with low-risk pulmonary embolism at home

Supporting the treatment of patients with low-risk pulmonary embolism at home

Supporting the treatment of patients with low-risk pulmonary embolism at home

The importance of real-world evidence: A look at stroke prevention in atrial fibrillation

The importance of real-world evidence: A look at stroke prevention in atrial fibrillation

The importance of real-world evidence: A look at stroke prevention in atrial fibrillation

Keeping it simple: Single drug approaches to VTE treatment

Keeping it simple: Single drug approaches to VTE treatment

Keeping it simple: Single drug approaches to VTE treatment

The importance of preserving kidney function in atrial fibrillation

The importance of preserving kidney function in atrial fibrillation

The importance of preserving kidney function in atrial fibrillation

Where next in cancer-associated thrombosis?

Where next in cancer-associated thrombosis?

Where next in cancer-associated thrombosis?

Time for a change? Switching anticoagulants in patients with AF or VTE

Time for a change? Switching anticoagulants in patients with AF or VTE

Time for a change? Switching anticoagulants in patients with AF or VTE

High-risk patients with atrial fibrillation: The importance of protection

High-risk patients with atrial fibrillation: The importance of protection

High-risk patients with atrial fibrillation: The importance of protection

Understanding the risk of VTE recurrence: Who needs extended anticoagulation?

Understanding the risk of VTE recurrence: Who needs extended anticoagulation?

Understanding the risk of VTE recurrence: Who needs extended anticoagulation?

ESC Heart and Stroke Conference: Highlights from Bayer 24–25 January 2020

ESC Heart and Stroke Conference: Highlights from Bayer 24–25 January 2020

ESC Heart and Stroke Conference: Highlights from Bayer 24–25 January 2020

Venous protection in 2019: A year in review

Venous protection in 2019: A year in review

Venous protection in 2019: A year in review

Stroke prevention in patients with AF in 2019: A year in review

Stroke prevention in patients with AF in 2019: A year in review

Stroke prevention in patients with AF in 2019: A year in review

Never miss out on the latest news!

Sign up to the Thrombosis Adviser newsletter.